Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.

Li-Lian Xu1, Geoffrey Liu, David P Miller

  • 1Occupational Health Program, Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
|December 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing for gene-environment interaction under exposure misspecification.

Biometrics·2017
Same author

Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer.

Molecular carcinogenesis·2017
Same author

Updating the "Risk Index": A systematic review and meta-analysis of occupational injuries and work schedule characteristics.

Chronobiology international·2017
Same author

Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.

Carcinogenesis·2017
Same author

Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients.

Oncotarget·2017
Same author

Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017
Same journal

Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Retraction: Menstrual Factors, Reproductive History and Liver Cancer Risk: Findings from a Prospective Cohort Study in Chinese Women.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Optimizing the Uptake and Completion of the Cervical Cancer Screening Continuum: Opportunity Knocks, Including at Home.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Sex Differences in Cancer Stage at Diagnosis of Nonreproductive Solid Organ Tumors in the United States, 2015 to 2022.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Evaluation of the 4Kscore in EPIC: Reply.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Evaluation of the 4Kscore in EPIC: Letter.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
See all related articles

The myeloperoxidase (MPO) gene polymorphism, previously linked to reduced lung cancer risk, showed no significant association in this large study. This suggests the MPO A allele may not protect against lung cancer, contrary to earlier findings.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Epidemiology

Background:

  • The myeloperoxidase (MPO) G-to-A polymorphism in the MPO gene promoter has been implicated in lung cancer risk.
  • Previous studies suggested a protective effect of the MPO A allele, potentially due to reduced carcinogen activation.

Purpose of the Study:

  • To investigate the association between the MPO G-to-A polymorphism and lung cancer risk in a large Caucasian cohort.
  • To validate or refute previous findings on the protective role of the MPO A allele.

Main Methods:

  • A case-control study involving 988 lung cancer cases and 1128 controls.
  • Logistic regression analysis was used to assess the association between MPO genotype and lung cancer risk, adjusting for covariates.
  • Stratified analyses were performed based on smoking status and other demographic and clinical factors.

Related Experiment Videos

Main Results:

  • The A allele frequency in controls was 21%, with genotype distribution in Hardy-Weinberg equilibrium.
  • No significant association was found between MPO genotypes (A/A, A/G) and lung cancer risk compared to the G/G genotype (ORs 1.15 and 1.03, respectively).
  • Stratified analyses by smoking status, age, disease stage, and histological subtype also revealed no significant associations.

Conclusions:

  • This study found no evidence that the MPO G-to-A polymorphism is associated with a reduced risk of lung cancer.
  • The findings contradict earlier studies and suggest the MPO A allele does not confer a protective effect against lung cancer in this population.